tiprankstipranks
Trending News
More News >
Recursion Pharmaceuticals (RXRX)
NASDAQ:RXRX
US Market
Advertisement

Recursion Pharmaceuticals (RXRX) Revenue

Compare
4,100 Followers

Recursion Pharmaceuticals Revenue

Recursion Pharmaceuticals had a revenue of 5.17M in the quarter ending Sep 30, 2025, with -72.91%. This bring the company's revenue in the last twelve months to 43.53M, Increased -32.44%. In the fiscal year ending Dec 31, 2024, Recursion Pharmaceuticals had annual revenue of 58.84M with 32.00% growth.
Revenue (ttm)
43.53M
Revenue Growth
-32.98%
P/S Ratio
34.13
Revenue/Employee
$73,549
Employees
800
Market Cap
$2.01B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
58.84M14.26M+132.00%
Dec 31, 2023
44.58M4.89M+112.33%
Dec 31, 2022
39.68M29.68M+396.81%
Dec 31, 2021
10.00M6.59M+293.00%
Dec 31, 2020
3.41M1.70M+199.47%
Dec 31, 2019
1.71M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis